ā Back to Trial
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Trial Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
- Contact: National Cancer Institute Referral Office Ā· 888-624-1937

